Status:
TERMINATED
Interest of Continuous Ropivacaine Administration Through an Elastomeric Pump (Pain Buster) for the Surgery of Latissimus Dorsi and Serratus Micro Anastomotic Flaps
Lead Sponsor:
Nantes University Hospital
Conditions:
Post Operative Analgesia
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Continuous bupivacaine administration through an elastomeric pump (Pain Buster) has been found effective for post operative analgesia in a large range of surgery. Ropivacaine is a less toxic drug, nev...
Eligibility Criteria
Inclusion
- operated for latissimus dorsi and serratus micro anastomotic flaps.
- 18 to 75 years old
- ASA I-II
- hospitalized in Nantes CHU Burns ICU
- giving their written informed consent
- with healthcare protection
Exclusion
- declining the study
- with known sides effects with morphine and local anesthetics
- with known allergy or other reaction with used drugs
- with disease incompatible with anaesthetic procedure
- under law protection
- taking antiepileptic or antidepressant drugs
- pregnant (not any gender criteria)
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00724685
Start Date
January 1 2008
End Date
November 1 2011
Last Update
February 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU
Nantes, France, 44093